$3.53
1.15% yesterday
Nasdaq, Jun 12, 10:03 pm CET
ISIN
CA10778Y3023
Symbol
BCTX
Sector
Industry

BriaCell Therapeutics Corp Stock price

$3.53
+0.41 13.14% 1M
-6.39 64.41% 6M
-4.95 58.35% YTD
-16.12 82.04% 1Y
-3.56 50.21% 5Y
-61.57 94.58% 10Y
-374.77 99.07% 20Y
Nasdaq, Closing price Thu, Jun 12 2025
+0.04 1.15%
ISIN
CA10778Y3023
Symbol
BCTX
Sector
Industry

Key metrics

Market capitalization $20.33m
P/E (TTM) P/E ratio negative
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-27.32m
Free Cash Flow (TTM) Free Cash Flow $-21.99m
EPS (TTM) EPS $-4.29
Short interest 7.80%

Is BriaCell Therapeutics Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

BriaCell Therapeutics Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast BriaCell Therapeutics Corp:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast BriaCell Therapeutics Corp:

Buy
100%

Financial data from BriaCell Therapeutics Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.91 5.91
22% 22%
-
- Research and Development Expense 21 21
11% 11%
-
-27 -27
14% 14%
-
- Depreciation and Amortization 0.12 0.12
500% 500%
-
EBIT (Operating Income) EBIT -27 -27
14% 14%
-
Net Profit -12 -12
8% 8%
-

In millions USD.

Don't miss a Thing! We will send you all news about BriaCell Therapeutics Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BriaCell Therapeutics Corp Stock News

Neutral
GlobeNewsWire
9 days ago
PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces today that the Company will be conducting two virtual investor presentations on Thursday, June 12, at 12:00 P...
Neutral
GlobeNewsWire
11 days ago
PHILADELPHIA and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today presents clinical data in three clinical poster presentations and one publish-only abstract at the 2025 American ...
Neutral
GlobeNewsWire
17 days ago
PHILADELPHIA and VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ; TSX: BCT), a clinical-stage biotechnology company advancing personalized immunotherapies for cancer, today announced that Bria-OTS has cleared its safety evaluation in the Phase 1/2 monotherapy study and has now transitioned to dosing patients in combination wi...
More BriaCell Therapeutics Corp News

Company Profile

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Head office Canada
CEO William Williams
Employees 16
Founded 2006
Website briacell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today